Font Size:
a
A
A
Keyword [Chronic graft versus host disease]
Result: 41 - 59 | Page: 3 of 3
41.
Study Of Bcl-6 Downregulation To Prevent Chronic Graft Versus Host Disease
42.
Clinical Efficacy And Safety Of Ruxolitinib In The Treatment Of Chronic Graft-versus-host Disease
43.
Analysis Of Risk Factors For Pulmonary Chronic Graft-versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
44.
Establishment And Indentification Of A Mice Model Of Chronic Graft-verse-hoet Disease With Oral Lesions
45.
The Clinical Study Of Chronic Graft-versus-host Disease Following Haploidentical Transplantation Combined Infusion With A Third Party Cord Blood
46.
Clinical Observation Of Sirolimus In The Treatment Of Refractory Chronic Graft-Versus-Host-Disease
47.
The Role Of Extrafollicular Helper T-like Cells In Patient With Chronic Graft-Versus-host Disease
48.
A Meta-analysis Of The Efficacy Of Mesenchymal Stem Cells In The Treatment Of Chronic Graft Versus Host Disease
49.
Study On The Risk Factors And Diagnostic Biomarkers Of Chronic Graft-versus-host Disease
50.
The Role Of Tfh Cell And B Cell In The Progression Of Chronic Graft Versus Host Disease In Human
51.
Preliminary Study On Ruxolitinib In The Salvage Treatment Of Refractory Pulmonary Chronic Graft-Versus-Host Disease(Bronchiolitis Obliterans Syndrome)
52.
The Role And Mechanism Of BET Inhibitor I-BET151 In Chronic Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
53.
Symptoms, functional status, and altered immunity in survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
54.
Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation
55.
The Role Of Nestin+Mesenchymal Stem Cells(MSCs) In Bone Marrow Chronic Graft-Versus-Host Disease
56.
Fecal Microbiota Transplantation For Acute And Chronic Graft-versus-host Disease:A Pilot Study And Systematic Review
57.
Alleviation Of Murine Sclerodermatous Chronic Graft Versus Host Disease By The Nrf2 Activator Mangiferin
58.
Sirolimus In Combination With Calcineurin Inhibitors For Hormone Resistant/dependentcGVHD
59.
Fibronectin Regulates Chronic Graft-versus-host Disease By Influencing Infiltration Of Alternatively Activated Macrophages
<<First
<Prev
Next>
Last>>
Jump to